上海元戊医学技术有限公司

Location： Home > News > Technological Frontier

Nat Cell Biol | Heavy! Scientists have developed the first-ever cardiac organoid that can produce blood!

18

2024-12

2024-12-18

Scientists have turned their attention to a magical small laboratory product-organoids.
Reveal iMSC: Why is it more popular than traditional MSC?

19

2024-11

2024-11-19

Compared with traditional MSC, iPSC-MSC not only has better proliferation ability, but also has a lower risk of age-related variability and heterogeneity.
Autologous induced neural stem cells for Parkinson's disease: Xuanwu Hospital's first patient achieved significant results

15

2024-11

2024-11-15

It was confirmed that after receiving iNSCDAP treatment, the transplanted dopaminergic nerve cells survived and released neurotransmitters, repairing neural function.
Bioactive Materials| Professor He Zhiying's team from Dongfang Hospital Affiliated to Tongji University established amplification conditions for determining hormone and chemical composition of bile duct tree stem cell organoids

25

2024-10

2024-10-25

This study successfully established the BEX system and achieved large-scale expansion of BTSC and its organoids in vitro.
Nature methods | Differentiation of visceral sensory ganglion organoids from induced pluripotent stem cells

23

2024-10

2024-10-23

This study successfully established a new protocol for the differentiation of visceral sensory ganglion organoids (VSGOs) from human induced pluripotent stem cells (iPSCs).
Cell Stem Cell丨 Deng Hongkui's team used chemical reprogramming technology to induce dedifferentiation of human cells and prepare large-scale expandable human embryonic limb blade-like cells

22

2024-10

2024-10-22

This study further proved that chemical reprogramming technology can induce Chemically induced dedifferentiation of human cells and successfully prepare large-scale expanded embryonic limb budd-like precursor cells.
Shanxi Academy of Medical Sciences issued a document to discuss whether induced pluripotent stem cell-derived mesenchymal stem cells (iMSC) can lead a new direction in cell therapy

09

2024-10

2024-10-09

In recent years, stem cell therapy has become a research hotspot in the biomedical field, and donor stem cells have been used for decades in multiple research and clinical treatments.
China's 30-year investigation report on diabetes released: With more than 117 million patients, cell therapy has become an important hope

08

2024-10

2024-10-08

On October 7, 2024,"Analysis of the National Burden and Risk Factors of Diabetes in China from 1990 to 2021: Results of the Global Disease Burden Study in 2021" was released in the Journal of Diabetes.

Prev

1 2 3 4 5 ...

Next